Catalyst Wire Dossier Catalyst Wire Dossier

TransCutaneous Hormones

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TransCutaneous Hormones, covering 2020-11-27 to 2020-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Prostate Adenocarcinoma TransCutaneous Hormones [Phase 3]

See pricing